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During excitation-contraction coupling in ventricular muscle (see ref.
1 for review), the L-type Ca 2+ current (I Ca ) acts as the main trigger for the release of Ca 2+ from the sarcoplasmic reticulum (SR); however, Na + /Ca 2+ exchange (NCX) acting in reverse mode may also contribute to Ca 2+ influx during the initial phase of the ventricular action potential. Relaxation is initiated by the decline of cytosolic Ca
2+
; predominately Ca 2+ is resequestered by the SR but under steady-state conditions, Ca 2+ that entered the cell during excitation via I Ca (and any via reverse mode NCX) must be extruded. This occurs predominately via NCX in forward mode with plasmalemmal Ca 2+ ATPase (PMCA) playing a lesser role in Ca 2+ efflux. 2 At steady state, it is well established that volatile anaesthetics induce a negative inotropic effect in ventricular muscle predominately as a result of their inhibitory action on I Ca 3-9 and myofilament Ca 2+ sensitivity. [10] [11] [12] [13] [14] NCX plays an important role in the regulation of cytosolic Ca 2+ as it represents the main Ca 2+ extrusion pathway from ventricular cells. However, the effect of volatile anaesthetics on the biophysics of this exchanger has not been studied in great detail especially in adult ventricular tissue. Previous experiments to assess the effect of volatile anaesthetics on NCX function have been carried out in both neonatal 15 16 and adult cells [16] [17] [18] and the majority have used flux measurements to assess anaesthetic-induced changes in Ca 2+ efflux (normal mode) or Ca 2+ influx (reverse mode) via NCX. The results of these studies suggest that both Ca 2+ efflux and influx are inhibited by volatile anaesthetics and that for halothane and sevoflurane the effects are greater in neonatal than adult ventricular cells. 19 However, in flux experiments, competing Ca 2+ transport pathways are inhibited pharmacologically or by ionic substitution and therefore, the results are critically dependent upon both the efficacy of pharmacological block and whether efficacy is affected by the introduction of anaesthetics. Furthermore, flux measurements of Ca 2+ efflux via NCX need to be corrected for the intracellular [Ca 2+ ] at which the measurements were taken. 18 A more direct measurement of NCX activity is to record changes in membrane current associated with the operation of NCX under conditions where ionic concentrations are well controlled. 20 With every cycle, three Na + are exchanged for one Ca 2+ such that in normal (Ca 2+ efflux) mode, inward current is generated and in reverse (Ca 2+ influx) mode, outward current is induced. The aims of these experiments were: (i) to test the hypothesis that 0.6 mM halothane and sevoflurane inhibit both inward and outward NCX current; (ii) to describe the effects of this concentration of anaesthetic on the current-voltage relationship of NCX; and (iii) to consider the potential role of this exchanger in the inotropic effects of halothane and sevoflurane.
Methods
Animal procedures conformed to regulations described in the Animals (Scientific Procedures) Act 1986, UK government Home Office. The experiments were carried out on Wistar rats ($250 g, Central Biomedical Services, University of Leeds), which were given access to food and water ad libitum and maintained under a 12-h light/dark cycle. Animals were killed by a schedule 1 procedure sanctioned by the UK government Home Office, the heart rapidly excised and ventricular myocytes isolated using a standard collagenase/ protease dispersion technique. 12 Myocytes were transferred to a circular chamber mounted on an inverted microscope (Nikon Eclipse) and superfused (at $2.5 ml min À1 ) with a physiological salt solution (PSS) containing (in mM): NaCl 140; KCl 4; CaCl 2 2.5; MgCl 2 1.2; glucose 10; HEPES 5, pH 7.4 (NaOH), 30 C. Anaesthetics were delivered from stock solutions made up in dimethyl sulphoxide (DMSO) to a final concentration of 0.6 mM.
[DMSO] never exceeded 0.2%, which had no effect on membrane current.
Electrophysiological recording
The whole-cell patch-clamp technique was used to control membrane voltage. Patch pipettes (Clark patch-clamp borosilicate capillaries) were pulled to a resistance of 1-2 MV (Narishige, PP-830) and fire-polished to 2.5-4 MW (Narishige MF83 microforge). Recordings of membrane currents were made using an Axopatch 200B (Axon Instruments, USA) amplifier with a CV-203BU headstage. Normally 80-90% of the pipette series resistance was compensated. Cell membrane capacitance was measured by integrating the capacitance current recorded during a 10-mV hyperpolarizing pulse from À80 mV.
Once whole-cell clamp conditions were achieved, all external solutions were applied to the cell under study using a multi-barreled, temperature controlled superfusion device. A Cs + -based internal dialysis solution was used for all recordings. Its composition was as follows (in mM): CsCl 110; NaCl 20; HEPES 10; MgCl 2 0.4; glucose 5; tetraethylammonium chloride 20; EGTA 5; MgATP 4; CaCl 2 1, titrated to pH 7.2 with CsOH. For measurement of I NCX , cells were superfused with a K + -free PSS (equimolar substitution with Cs + ) supplemented with 10 mM nifedipine and 10 mM strophanthidin (to inhibit I Ca and the Na + /K + ATPase, respectively). Holding potential was set at À40 mV. Membrane potential was then clamped to +50 mV for 100 ms and then ramped to À120 mV over a period of 2.5 s (i.e. at 68 mV s À1 ) before returning to À40 mV. Ramp clamps were repeated in the same cell in the presence of 5 mM Ni 2+ to inhibit NCX and the putative I NCX measured as the difference current (i.e. the Ni 2+ -sensitive current). Ni 2+ was then removed and if membrane current did not return to control, then the cell was excluded from analysis. The ramp clamp protocol was then repeated in each cell in the presence of either 0.6 mM halothane or 0.6 mM sevoflurane, a dose that is clinically relevant [approximately twice the minimum alveolar concentration (MAC) for the rat] and approximately equi-anaesthetic. These experiments generated Ni 2+ -sensitive membrane currents in the absence and presence of anaesthetic in each cell. Current magnitude was scaled for cell capacitance and assessed at 10 mV intervals (between À120 and +50 mV) to allow construction of mean current-voltage relationships in the absence and presence of anaesthetic. In cells where complete post-control data sets were recorded, the effects of halothane and sevoflurane on I NCX were reversible. 
Statistical analysis
Data are presented as mean (SEM) of n determinations (number of cells) and statistical comparisons were performed with paired Student's t-tests using SigmaStat (Jandel Scientific, Erkrath, Germany) or Wilcoxon's signed rank test if data failed a standard normality test (KolmogorovSmirnov). All figures were prepared by using SigmaPlot (Jandel Scientific).
Results

Figure 1 illustrates representative Ni
2+ -sensitive membrane current traces (i.e. putative I NCX ) in response to the ramp clamp protocol (A) in the absence and presence of 0.6 mM halothane (B) and 0.6 mM sevoflurane (C). These illustrate that at membrane potentials positive to the reversal potential, outward current was generated that was reduced in magnitude by anaesthetic. Similarly, inward current (evoked at potentials negative to the reversal potential) was also inhibited by exposure to halothane and sevoflurane. Figure 2A illustrates the mean current-voltage relationship for I NCX in the absence (open symbols) and presence (filled symbols) of 0.6 mM sevoflurane. The reversal potential was very close to À40 mV and was not shifted by the introduction of sevoflurane. At voltages equal or positive to 0 mV (P<0.05) and negative to À60 mV (P<0.05), sevoflurane significantly reduced I NCX ; for example, at +50, +20, À80, and À120 mV, current was reduced by 48, 53, 53, and 65% of control, respectively. Sevoflurane-sensitive I NCX reversed close to À40 mV and was effectively linear over the voltage range (Fig. 2B) . Similar current-voltage relationships were observed for experiments conducted with halothane (not shown). As for sevoflurane, halothane did not induce a shift in the reversal potential and both outward and inward I NCX were inhibited; for example, at +50, +20, À80, and À120 mV, current was reduced by 64, 76, 57, and 65% of control, respectively. Figure 3 shows a comparison of the efficacy of block of halothane and sevoflurane on inward I NCX (between À60 and À120 mV) and outward I NCX (between 0 and +50 mV). This illustrates that block by sevoflurane and halothane of both inward and outward I NCX was not voltage-dependent and that the extent of block of both inward and outward I NCX was broadly equivalent for both anaesthetics (the apparent greater inhibition of outward I NCX by halothane was not significantly different to data obtained with sevoflurane).
Discussion
These data describe the effects of halothane and sevoflurane on the current-voltage relationship of NCX and for the first time illustrate in adult ventricular myocytes that (i) both halothane and sevoflurane significantly inhibit inward and outward I NCX to a similar extent at the concentration tested and (ii) show that the inhibition of I NCX by both anaesthetics is not voltage-dependent. Previous data on the effects of volatile anaesthetics on I NCX is sparse. One previous study 15 reported a 66% reduction in outward membrane current at +60 mV by halothane 3% in rabbit neonatal ventricular cells, however in that study, inward current was not measured. This compares favourably with data from the present study where 0.6 mM halothane inhibited outward I NCX by 64% at +50 mV. Our data also support previous conclusions from experiments using radioisotope flux measurement in which 0.91 mM halothane reduced Ca 2+ influx (i.e. outward I NCX ) by 50%.
17
More recent experiments 18 investigated the dosedependent effects of 1 and 2 MAC halothane and sevoflurane on the rates of both Ca 2+ influx and efflux in adult rat ventricular myocytes; halothane (2 MAC) inhibited Ca 2+ influx (equivalent to outward I NCX ) and efflux (equivalent to inward I NCX ) by approximately 71 and 50%, values very similar to those reported here (see Fig. 3 ). Data derived from Seckin and co-workers 18 indicate that 2 MAC sevoflurane inhibited Ca 2+ influx by approximately 67% and Ca 2+ efflux by approximately 48%. In the present study, we found 0.6 mM sevoflurane inhibited outward I NCX by 48% (at +50 mV) and inward I NCX by 53% (at À80 mV). Although only one, high concentration of anaesthetic ($2 MAC) was studied in the present report, there is very good agreement between data derived from Ca 2+ flux measurements with 2 MAC anaesthetic and direct measurement of I NCX for halothane and sevoflurane. Furthermore, because of the apparent lack of voltagedependence of block of I NCX by halothane and sevoflurane this minimizes the impact of changes in membrane potential on Ca 2+ flux rate, which was considered to be a potential confounding variable.
18
The impact of block of NCX by halothane and sevoflurane on the regulation of intracellular Ca 2+ and therefore contractility will depend on the balance between normal and reverse mode of the exchanger as both modes are inhibited to a similar extent by both anaesthetics. It is generally conceded that under normal physiological conditions, Ca 2+ entry via NCX (reverse mode) plays only a minor role in the Ca 2+ influx, which triggers SR Ca 2+ release 21 22 and therefore, it follows that the normal mode of operation of NCX is to extrude Ca 2+ from the cell. Given that inward current is inhibited at the resting membrane potential this would be expected to reduce Ca 2+ efflux via NCX during diastole. This would offset the reduction in Ca 2+ entry via I Ca and help to maintain SR Ca 2+ content and contractility. Furthermore, as Ca 2+ efflux from the cell via NCX generates an inward depolarizing current, inhibition of this current would also contribute to the reduction in action potential duration observed in ventricular cells during exposure to halothane or sevoflurane. 3 Lynch C III, Vogel S, Sperelakis N. Effects of halothane and sevoflurane on I NCX
